- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01738334
Effects Of The Mindfulness Meditation Practices On Cognition
November 28, 2012 updated by: Viviane Freire Bueno, Federal University of São Paulo
EVALUATION OF THE EFFECTS OF THE MINDFULNESS MEDITATION PRACTICES ON COGNITION OF ADULTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
Adults with Attention Deficit Hyperactivity Disorder (ADHD) have impairments in attentional subsystems of alerting and conflict monitoring.
Mindfulness meditation may lead to an improvement of these deficits, and reduces symptoms of anxiety and depression.
However, the studies that demonstrated these improvements did not use a control group, nor controlled the use of medication.
In the present study the investigators will examine the effects of the mindfulness practices (same protocol of 8 weekly sessions used in the study that showed positive effects in this disorder) in the performance of adult patients and healthy people (with ADHD).
Cognitive performance, mood, and the quality of life will be assessed by validated questionnaires before and after treatment/standby.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 04023062
- Federal University of São Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Portuguese as their first language;
- minimum of eight years of formal education;
- normal vision or corrected to normal and normal hearing;
- no prior experience with meditation;
- patients should be taking stable doses of methylphenidate (for at least a month) for their disorder as prescribed by their doctors.
Exclusion Criteria:
- patients with neurological and psychiatric disorders such as psychosis, obsessive-compulsive disorder or Tourette's syndrome.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Healthy subjects
The "active" control group of healthy individuals was subjected to the practice of meditation for eight weeks.
|
The control group with healthy subjects that was participate in meditation ("active" control group)
|
|
No Intervention: Standby
The control group of participants (patients and healthy subjects) who was not practice anything for eight weeks.
|
|
|
Experimental: Meditation
A Group of Patients with ADHD was participate of the meditation practices for eight weeks.
|
In the eight weeks following the first session of cognitive tests, the participants made a practice of weekly meditation group lasting 2 hours.
Practices with each group (patients and "active" controls) occurred on different days.
With regard to meditation practices were performed in a sitting posture with emphasis on daily life.
Each weekly session involved meditation practices with trained professional, practical proposals for home exercise and a discussion group.
Meditation compact discs (CDs)were given to participants for practices at home, which proposed activities for 5 minutes to 1 week and 2 weeks for 10 minutes 3-5, and finally 15 minutes for 6-8 weeks.
After 8 weeks of treatment the second session of tests was held that involved the same tasks in session 1.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the ADHD symptoms before to the meditation and after 8 weeks to the meditation.
Time Frame: change from baseline in ADHD symptoms at 8 weeks
|
The symptoms of inattention and hyperactivity / impulsivity were evaluated by means the Adult self-report scale (ASRS).
|
change from baseline in ADHD symptoms at 8 weeks
|
|
Evaluate the executive functions
Time Frame: 1 day
|
The executive functions tests were applied before to the meditation, so that to avoid learning.
|
1 day
|
|
Evaluate the mood symptoms before to the meditation and 8 weeks after to the meditation.
Time Frame: change from baseline in mood symptoms at 8 weeks.
|
The symptoms of anxiety and depression were evaluated by means of the following scales: Trait Anxiety Inventory (STAI-Trait), and Beck Depression Scale, respectively, and the visual-analog scales of mood (VAMS)and Positive and negative Affect Schedule extended (PANAS-X).
|
change from baseline in mood symptoms at 8 weeks.
|
|
Evaluate the quality of life before to the meditation and 8 weeks after to the meditation.
Time Frame: change from baseline in quality of life at 8 weeks.
|
Quality of Life was evaluated by means of the Questionnaire in Adults with ADHD (AAQoL).
|
change from baseline in quality of life at 8 weeks.
|
|
Evaluate the attention before to the meditation and 8 weeks after to the meditation.
Time Frame: change from baseline in attention at 8 weeks.
|
The scores of attention was evaluated by Continuous Performance Test (CPT) and the Attentional Network Test (ANT).
|
change from baseline in attention at 8 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Sabine Pompéia, Postdoctoral, Federal University of São Paulo
- Principal Investigator: Viviane F Bueno, Doctor, Federal University of São Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
February 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
November 11, 2012
First Submitted That Met QC Criteria
November 28, 2012
First Posted (Estimate)
November 30, 2012
Study Record Updates
Last Update Posted (Estimate)
November 30, 2012
Last Update Submitted That Met QC Criteria
November 28, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EMC 001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder With Hyperactivity
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Istituto Giannina GasliniUniversity of Genova; IRCCS Fondazione Stella MarisRecruitingADHD - Attention Deficit Disorder With HyperactivityItaly
-
Dlniya Ismail RashidActive, not recruitingADHD - Attention Deficit Disorder With HyperactivityIraq
-
Hoskinson Health and Wellness ClinicWithdrawnAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Tanta UniversityActive, not recruitingAttention Deficit Disorder With Hyperactivity (ADHD)Egypt
-
Gaziantep Islam Science and Technology UniversityCompletedAttention Deficit Disorder With Hyperactivity (ADHD)Turkey (Türkiye)
-
Medipol UniversityEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD)Turkey (Türkiye)
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
Clinical Trials on Active comparator (meditation) with healthy subjects
-
University of California, San FranciscoCompleted
-
Vigonvita Life SciencesRecruiting
-
Università degli Studi di SassariDr. Dario Melodia; Dr. Milena Pisano; Prof. Silvio Mario Meloni; Prof. Edoardo... and other collaboratorsNot yet recruitingDental Implant | Dental Implant-Abutment DesignItaly
-
Beijing Wehand-Bio Pharmaceutical Co., LtdPeking University First HospitalCompletedHealthy | Overweight and ObesityChina
-
University of Alabama at BirminghamNational Eye Institute (NEI)Completed
-
National Taiwan University HospitalCompletedLifestyle Risk Reduction | Elderly Adults | Community DwellingTaiwan
-
Insulet CorporationCompletedType 2 Diabetes MellitusUnited States
-
ThromboGenicsBioInvent International ABCompleted
-
Assistance Publique - Hôpitaux de ParisRecruitingICU Patients Under Invasive Mechanical VentilationFrance
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedPresumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI)Preventive Health Services (PREV HEALTH SERV)United States